Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ayomide Victor Atoki, Patrick Maduabuchi Aja, Erick Nyakundi Ondari & Tijjani Salihu Shinkafi. (2023) Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches. International Journal of Food Properties 26:1, pages 2091-2127.
Read now
Read now
Guang Fang, Baoyan Shi, Kefeng Wu, Siyu Chen, Xiang Gao, Sa Xiao, Jing X. Kang, Wende Li & Ren Huang. (2019) The protective role of endogenous n-3 polyunsaturated fatty acids in Tau Alzheimer’s disease mouse model. International Journal of Neuroscience 129:4, pages 325-336.
Read now
Read now
Davide Seripa, Vincenzo Solfrizzi, Bruno P. Imbimbo, Antonio Daniele, Andrea Santamato, Madia Lozupone, Giovanni Zuliani, Antonio Greco, Giancarlo Logroscino & Francesco Panza. (2016) Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium. Expert Review of Neurotherapeutics 16:3, pages 259-277.
Read now
Read now
Articles from other publishers (55)
Kiarash Saleki, Mohammad Banazadeh, Amene Saghazadeh & Nima Rezaei. (2023) Aging, testosterone, and neuroplasticity: friend or foe?. Reviews in the Neurosciences 34:3, pages 247-273.
Crossref
Crossref
Christian BehlChristian Behl. 2023. Alzheimer’s Disease Research. Alzheimer’s Disease Research
227
260
.
Afreen Hashmi, Vivek Srivastava, Syed Abul Kalam & Devesh Kumar Mishra. 2022. Alzheimer's Disease. Alzheimer's Disease.
Hadeel Y. Tarawneh, Dona M.P. Jayakody, Hamid R. Sohrabi, Ralph N. Martins & Wilhelmina H.A.M. Mulders. (2022) Understanding the Relationship Between Age-Related Hearing Loss and Alzheimer’s Disease: A Narrative Review. Journal of Alzheimer's Disease Reports 6:1, pages 539-556.
Crossref
Crossref
Livia La Barbera, Emanuele Mauri, Marcello D’Amelio & Manuele Gori. (2022) Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives. Frontiers in Neuroscience 16.
Crossref
Crossref
Hamed Kazemi Shariat Panahi, Mona Dehhaghi, Benjamin Heng, Darius J. R. Lane, Ashley I. Bush, Gilles J. Guillemin & Vanessa X. Tan. (2022) Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis. Neurotoxicity Research 40:2, pages 614-635.
Crossref
Crossref
Minghao Yuan, Yangyang Wang, Jie Wen, Feng Jing, Qian Zou, Yinshuang Pu, Tingyu Pan & Zhiyou Cai. (2022) Dietary Salt Disrupts Tricarboxylic Acid Cycle and Induces Tau Hyperphosphorylation and Synapse Dysfunction during Aging. Aging and disease 13:5, pages 1532.
Crossref
Crossref
Hadeel Y. Tarawneh, Wilhelmina H.A.M. Mulders, Hamid R. Sohrabi, Ralph N. Martins & Dona M.P. Jayakody. (2021) Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies. Journal of Alzheimer's Disease 84:1, pages 419-448.
Crossref
Crossref
Julie Gregory, Yasaswi V. Vengalasetti, Dale E. Bredesen & Rammohan V. Rao. (2021) Neuroprotective Herbs for the Management of Alzheimer’s Disease. Biomolecules 11:4, pages 543.
Crossref
Crossref
Maryam Ghaffari, Nima Sanadgol & Mohammad Abdollahi. (2020) A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer’s Disease. Mini-Reviews in Medicinal Chemistry 20:15, pages 1499-1517.
Crossref
Crossref
Satya P. Gupta & Vaishali M. Patil. (2020) Recent Studies on Design and Development of Drugs Against Alzheimer’s Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents. Current Topics in Medicinal Chemistry 20:13, pages 1195-1213.
Crossref
Crossref
Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, Terence J. O’Brien, Patrick Kwan, Christina Piperi, Iekhsan Othman & Mohd. Farooq Shaikh. (2019) Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease. ACS Chemical Neuroscience 10:10, pages 4199-4212.
Crossref
Crossref
Howard Friel. (2019) Biopharmaceutical Monotargeting versus ‘Universal Targeting’ of Late-Onset Alzheimer’s Disease Using Mixtures of Pleiotropic Natural Compounds. Journal of Alzheimer's Disease Reports 3:1, pages 219-232.
Crossref
Crossref
Miren Ettcheto, Amanda Cano, Oriol Busquets, Patricia Regina Manzine, Elena Sánchez-López, Rubén D. Castro-Torres, Carlos Beas-Zarate, Ester Verdaguer, María Luisa García, Jordi Olloquequi, Carme Auladell, Jaume Folch & Antoni Camins. (2019) A metabolic perspective of late onset Alzheimer’s disease. Pharmacological Research 145, pages 104255.
Crossref
Crossref
Kamlesh Sharma. (2019) Cholinesterase inhibitors as Alzheimer's therapeutics (Review). Molecular Medicine Reports.
Crossref
Crossref
Hao Wang, Haijuan Sui, Yan Zheng, Yibing Jiang, Yijie Shi, Jia Liang & Liang Zhao. (2019) Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3β pathway. Nanoscale 11:15, pages 7481-7496.
Crossref
Crossref
Geir Bjørklund, Alexey A. Tinkov, Maryam Dadar, Md. Mostafizur Rahman, Salvatore Chirumbolo, Anatoly V. Skalny, Margarita G. Skalnaya, Boyd E. Haley, Olga P. Ajsuvakova & Jan Aaseth. (2019) Insights into the Potential Role of Mercury in Alzheimer’s Disease. Journal of Molecular Neuroscience.
Crossref
Crossref
Pegah Javadpour, Leila Dargahi, Abolhassan Ahmadiani & Rasoul Ghasemi. (2019) To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling. Cellular and Molecular Life Sciences.
Crossref
Crossref
Haibo Zhang, Ding Wang, Ping Gong, Aihua Lin, Yan Zhang, Richard D. Ye & Yang Yu. (2019) Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease 67:1, pages 169-179.
Crossref
Crossref
Jyoti Gupta & Mehboob Hoque. 2019. Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease. Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease
271
293
.
Chao Wu, Wei-Gang Gong, Yan-Juan Wang, Jun-Jun Sun, Hong Zhou, Zhi-Jun Zhang & Qing-Guo Ren. (2018) Escitalopram alleviates stress-induced Alzheimer's disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin/GSK-3β signal pathway activity. Neurobiology of Aging 67, pages 137-147.
Crossref
Crossref
Gustavo Basurto-Islas, Jin-hua Gu, Yunn Chyn Tung, Fei Liu & Khalid Iqbal. (2018) Mechanism of Tau Hyperphosphorylation Involving Lysosomal Enzyme Asparagine Endopeptidase in a Mouse Model of Brain Ischemia. Journal of Alzheimer's Disease 63:2, pages 821-833.
Crossref
Crossref
Ai-Hua Xu, Yang Yang, Yong-Xin Sun & Chao-Dong Zhang. (2018) Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer's disease. Neural Regeneration Research 13:12, pages 2173.
Crossref
Crossref
Mange Ram Yadav, Mahesh A. Barmade, Rupesh V. Chikhale & Prashant R. Murumkar. 2018. Computational Modeling of Drugs Against Alzheimer’s Disease. Computational Modeling of Drugs Against Alzheimer’s Disease
347
417
.
Nicolas Delcourt, Thomas Claudepierre, Thomas Maignien, Nathalie Arnich & César Mattei. (2017) Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy. Toxins 10:1, pages 6.
Crossref
Crossref
Daisuke Tanokashira, Naomi Mamada, Fumiko Yamamoto, Kaori Taniguchi, Akira Tamaoka, Madepalli K. Lakshmana & Wataru Araki. (2017) The neurotoxicity of amyloid ?-protein oligomers is reversible in a primary neuron model. Molecular Brain 10:1.
Crossref
Crossref
Agnieszka Wnuk & Małgorzata Kajta. (2017) Steroid and Xenobiotic Receptor Signalling in Apoptosis and Autophagy of the Nervous System. International Journal of Molecular Sciences 18:11, pages 2394.
Crossref
Crossref
Veena Theendakara, Dale E. Bredesen & Rammohan V. Rao. (2017) Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease. Molecular and Cellular Neuroscience 83, pages 83-91.
Crossref
Crossref
J. Alex Grizzell, Sagar Patel, George E. Barreto & Valentina Echeverria. (2017) Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 78, pages 75-81.
Crossref
Crossref
Cristina Di Primio, Valentina Quercioli, Giacomo Siano, Matteo Rovere, Branislav Kovacech, Michal Novak & Antonino Cattaneo. (2017) The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Bernd Janssen & Bernd Schäfer. (2017) Galantamine. ChemTexts 3:2.
Crossref
Crossref
Howard Friel & Sally Frautschy. 2017. A Paradigm Shift to Prevent and Treat Alzheimer's Disease. A Paradigm Shift to Prevent and Treat Alzheimer's Disease
89
149
.
S. Mondragón-Rodríguez, G. Perry & F. Peña-Ortega. 2017. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders
145
160
.
Karoline T. Neumann, Anders T. Lindhardt, Benny Bang-Andersen & Troels Skrydstrup. (2017)
Synthesis and selective
2
H-,
13
C-, and
15
N-labeling of the Tau protein binder THK-523
. Journal of Labelled Compounds and Radiopharmaceuticals 60:1, pages 30-35.
Crossref
Crossref
Bei Zhang, Qiongqiong Li, Xingkun Chu, Suya Sun & Shengdi Chen. (2016) Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease. Translational Neurodegeneration 5:1.
Crossref
Crossref
Liang Zhao, Yan Xiao, Xiao-Liang Wang, Jinjing Pei & Zhi-Zhong Guan. (2016) Original Research: Influence of okadaic acid on hyperphosphorylation of tau and nicotinic acetylcholine receptors in primary neurons. Experimental Biology and Medicine 241:16, pages 1825-1833.
Crossref
Crossref
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno P Imbimbo, Madia Lozupone, Andrea Santamato, Rosanna Tortelli, Ilaria Galizia, Camilla Prete, Antonio Daniele, Alberto Pilotto, Antonio Greco & Giancarlo Logroscino. (2016) Tau-based therapeutics for Alzheimer’s disease: active and passive immunotherapy. Immunotherapy 8:9, pages 1119-1134.
Crossref
Crossref
David L. Sloman, Njamkou Noucti, Michael D. Altman, Dapeng Chen, Andrea C. Mislak, Alexander Szewczak, Mansuo Hayashi, Lee Warren, Tammy Dellovade, Zhenhua Wu, Jacob Marcus, Deborah Walker, Hua-Poo Su, Suzanne C. Edavettal, Sanjeev Munshi, Michael Hutton, Hugh Nuthall & Matthew G. Stanton. (2016) Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties. Bioorganic & Medicinal Chemistry Letters 26:17, pages 4362-4366.
Crossref
Crossref
Gang Wang, Yue Huang, Li-Ling Wang, Yong-Fang Zhang, Jing Xu, Yi Zhou, Guinevere F. Lourenco, Bei Zhang, Ying Wang, Ru-Jing Ren, Glenda M. Halliday & Sheng-Di Chen. (2016) MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer’s disease. Scientific Reports 6:1.
Crossref
Crossref
Eduardo E. Benarroch. (2016) Dynamics of microtubules and their associated proteins. Neurology 86:20, pages 1911-1920.
Crossref
Crossref
Yanjun Lu, Wei Liu, Kun Tan, Jing Peng, Yaowu Zhu & Xiong Wang. (2015) Genetic association of CALHM1 rs2986017 polymorphism with risk of Alzheimer?s disease: a meta-analysis. Neurological Sciences 37:4, pages 525-532.
Crossref
Crossref
Jaume Folch, Dmitry Petrov, Miren Ettcheto, Sonia Abad, Elena Sánchez-López, M. Luisa García, Jordi Olloquequi, Carlos Beas-Zarate, Carme Auladell & Antoni Camins. (2016) Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment. Neural Plasticity 2016, pages 1-15.
Crossref
Crossref
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno P. Imbimbo, Madia Lozupone, Andrea Santamato, Chiara Zecca, Maria Rosaria Barulli, Antonello Bellomo, Alberto Pilotto, Antonio Daniele, Antonio Greco & Giancarlo Logroscino. (2016) Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease. BioMed Research International 2016, pages 1-15.
Crossref
Crossref
Tangui Maurice. (2016) Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments. Behavioural Brain Research 296, pages 270-278.
Crossref
Crossref
M. Medina & J. Avila. 2016. Developing Therapeutics for Alzheimer's Disease. Developing Therapeutics for Alzheimer's Disease
327
341
.
Elizabeta B Mukaetova-Ladinska, Mosi Li & Raj N Kalaria. (2015) tau protein, ischemic injury and vascular dementia. Future Neurology 10:6, pages 559-575.
Crossref
Crossref
Fan Zhang, Bo Su, Chunyu Wang, Sandra L. Siedlak, Siddhartha Mondragon-Rodriguez, Hyoung-gon Lee, Xinglong Wang, George Perry & Xiongwei Zhu. (2015) Posttranslational modifications of α-tubulin in alzheimer disease. Translational Neurodegeneration 4:1.
Crossref
Crossref
Nataliya Golovyashkina, Lorène Penazzi, Carlo Ballatore, Amos B. SmithIIIIII, Lidia Bakota & Roland Brandt. (2015) Region-specific dendritic simplification induced by Aβ, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes. Molecular Neurodegeneration 10:1.
Crossref
Crossref
Chenxia Sheng, Weijun Peng, Zi-an Xia, Yang Wang, Zeqi Chen, Nanxiang Su & Zhe Wang. (2015) The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer?s disease: a systematic review. BMC Complementary and Alternative Medicine 15:1.
Crossref
Crossref
Gaëlle Naert, Valentine Ferré, Johann Meunier, Emeline Keller, Susanna Malmström, Laurent Givalois, François Carreaux, Jean-Pierre Bazureau & Tangui Maurice. (2015) Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice. European Neuropsychopharmacology 25:11, pages 2170-2182.
Crossref
Crossref
A. Caccamo, C. Branca, J. S. Talboom, D. M. Shaw, D. Turner, L. Ma, A. Messina, Z. Huang, J. Wu & S. Oddo. (2015) Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease. Journal of Neuroscience 35:41, pages 14042-14056.
Crossref
Crossref
Lisha Li, Yahui Peng, Yang Hui, Shuai Zhang, You Zhou, Dan Li, Jihong Li, Zizhen Si, Jing Li, Dayong Wang, Yanze Li, Min Dong & Xu Gao. (2015) Overexpression of Heme Oxygenase 1 Impairs Cognitive Ability and Changes the Plasticity of the Synapse. Journal of Alzheimer's Disease 47:3, pages 595-608.
Crossref
Crossref
Manuela Ariza, Hartmuth C. Kolb, Dieder Moechars, Frederik Rombouts & José Ignacio Andrés. (2015) Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future. Journal of Medicinal Chemistry 58:11, pages 4365-4382.
Crossref
Crossref
G. Halliday. (2014) Progressive supranuclear palsy finally has a clinically measureable ? abnormality. Journal of Neurology, Neurosurgery & Psychiatry 86:3, pages 241-241.
Crossref
Crossref
Fiona Gr?ninger. (2015) Invited review: Drug development for tauopathies. Neuropathology and Applied Neurobiology 41:1, pages 81-96.
Crossref
Crossref